Cargando…

Concurrent use of e-cigarettes and cannabis and associated COVID-19 symptoms, testing, and diagnosis among student e-cigarette users at four U.S. Universities

INTRODUCTION: This investigation assessed whether current (past 30-day) electronic cigarette (e-cigarette) and cannabis use was associated with coronavirus disease 2019 (COVID-19) symptomatology, testing, and diagnosis among college student e-cigarette users. METHODS: Participants were 18–26-year-ol...

Descripción completa

Detalles Bibliográficos
Autores principales: Merianos, Ashley L., Russell, Alex M., Mahabee-Gittens, E. Melinda, Barry, Adam E., Yang, Meng, Lin, Hsien-Chang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8570844/
https://www.ncbi.nlm.nih.gov/pubmed/34776303
http://dx.doi.org/10.1016/j.addbeh.2021.107170
_version_ 1784594900727103488
author Merianos, Ashley L.
Russell, Alex M.
Mahabee-Gittens, E. Melinda
Barry, Adam E.
Yang, Meng
Lin, Hsien-Chang
author_facet Merianos, Ashley L.
Russell, Alex M.
Mahabee-Gittens, E. Melinda
Barry, Adam E.
Yang, Meng
Lin, Hsien-Chang
author_sort Merianos, Ashley L.
collection PubMed
description INTRODUCTION: This investigation assessed whether current (past 30-day) electronic cigarette (e-cigarette) and cannabis use was associated with coronavirus disease 2019 (COVID-19) symptomatology, testing, and diagnosis among college student e-cigarette users. METHODS: Participants were 18–26-year-old college student e-cigarette users attending four geographically diverse, large U.S. public universities during October-December 2020 (N = 800). Multivariable logistic regression models explored associations between exclusive e-cigarette use and concurrent e-cigarette and cannabis use and COVID-19 symptoms, testing, and diagnosis. Models controlled for demographics, university site, and current use of combustible cigarettes, cigars, and smokeless tobacco. RESULTS: Over half of student e-cigarette users (52.0%) concurrently used cannabis. Compared to exclusive e-cigarette users, concurrent e-cigarette and cannabis users were 3.53 times more likely (95%CI = 1.96–6.36) to report COVID-19 symptoms, after adjusting for the covariates. Compared to infrequent exclusive e-cigarette users, infrequent concurrent users (AOR = 4.72, 95%CI = 1.31–17.00), intermediate concurrent users (AOR = 5.10, 95%CI = 1.37–18.97), and frequent concurrent users (AOR = 7.44, 95%CI = 2.06–26.84) were at increased odds of reporting COVID-19 symptoms. Compared to exclusive e-cigarette users, concurrent e-cigarette and cannabis users were 1.85 times more likely (95%CI = 1.15–2.98) to report a COVID-19 diagnosis. Intermediate concurrent users (AOR = 2.88, 95%CI = 1.13–7.35) and frequent concurrent users (AOR = 3.22, 95%CI = 1.32–7.87) were at increased odds of reporting a COVID-19 diagnosis, compared to infrequent exclusive e-cigarette users. CONCLUSIONS: Concurrent use of e-cigarettes and cannabis may be an underlying risk factor of COVID-19 symptomatology and diagnosis, with more pronounced odds found among intermediate and frequent users. Results highlight the need to educate students about the impacts of e-cigarette and cannabis use on respiratory, immune, and overall health.
format Online
Article
Text
id pubmed-8570844
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-85708442021-11-08 Concurrent use of e-cigarettes and cannabis and associated COVID-19 symptoms, testing, and diagnosis among student e-cigarette users at four U.S. Universities Merianos, Ashley L. Russell, Alex M. Mahabee-Gittens, E. Melinda Barry, Adam E. Yang, Meng Lin, Hsien-Chang Addict Behav Article INTRODUCTION: This investigation assessed whether current (past 30-day) electronic cigarette (e-cigarette) and cannabis use was associated with coronavirus disease 2019 (COVID-19) symptomatology, testing, and diagnosis among college student e-cigarette users. METHODS: Participants were 18–26-year-old college student e-cigarette users attending four geographically diverse, large U.S. public universities during October-December 2020 (N = 800). Multivariable logistic regression models explored associations between exclusive e-cigarette use and concurrent e-cigarette and cannabis use and COVID-19 symptoms, testing, and diagnosis. Models controlled for demographics, university site, and current use of combustible cigarettes, cigars, and smokeless tobacco. RESULTS: Over half of student e-cigarette users (52.0%) concurrently used cannabis. Compared to exclusive e-cigarette users, concurrent e-cigarette and cannabis users were 3.53 times more likely (95%CI = 1.96–6.36) to report COVID-19 symptoms, after adjusting for the covariates. Compared to infrequent exclusive e-cigarette users, infrequent concurrent users (AOR = 4.72, 95%CI = 1.31–17.00), intermediate concurrent users (AOR = 5.10, 95%CI = 1.37–18.97), and frequent concurrent users (AOR = 7.44, 95%CI = 2.06–26.84) were at increased odds of reporting COVID-19 symptoms. Compared to exclusive e-cigarette users, concurrent e-cigarette and cannabis users were 1.85 times more likely (95%CI = 1.15–2.98) to report a COVID-19 diagnosis. Intermediate concurrent users (AOR = 2.88, 95%CI = 1.13–7.35) and frequent concurrent users (AOR = 3.22, 95%CI = 1.32–7.87) were at increased odds of reporting a COVID-19 diagnosis, compared to infrequent exclusive e-cigarette users. CONCLUSIONS: Concurrent use of e-cigarettes and cannabis may be an underlying risk factor of COVID-19 symptomatology and diagnosis, with more pronounced odds found among intermediate and frequent users. Results highlight the need to educate students about the impacts of e-cigarette and cannabis use on respiratory, immune, and overall health. Elsevier Ltd. 2022-03 2021-11-01 /pmc/articles/PMC8570844/ /pubmed/34776303 http://dx.doi.org/10.1016/j.addbeh.2021.107170 Text en © 2021 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Merianos, Ashley L.
Russell, Alex M.
Mahabee-Gittens, E. Melinda
Barry, Adam E.
Yang, Meng
Lin, Hsien-Chang
Concurrent use of e-cigarettes and cannabis and associated COVID-19 symptoms, testing, and diagnosis among student e-cigarette users at four U.S. Universities
title Concurrent use of e-cigarettes and cannabis and associated COVID-19 symptoms, testing, and diagnosis among student e-cigarette users at four U.S. Universities
title_full Concurrent use of e-cigarettes and cannabis and associated COVID-19 symptoms, testing, and diagnosis among student e-cigarette users at four U.S. Universities
title_fullStr Concurrent use of e-cigarettes and cannabis and associated COVID-19 symptoms, testing, and diagnosis among student e-cigarette users at four U.S. Universities
title_full_unstemmed Concurrent use of e-cigarettes and cannabis and associated COVID-19 symptoms, testing, and diagnosis among student e-cigarette users at four U.S. Universities
title_short Concurrent use of e-cigarettes and cannabis and associated COVID-19 symptoms, testing, and diagnosis among student e-cigarette users at four U.S. Universities
title_sort concurrent use of e-cigarettes and cannabis and associated covid-19 symptoms, testing, and diagnosis among student e-cigarette users at four u.s. universities
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8570844/
https://www.ncbi.nlm.nih.gov/pubmed/34776303
http://dx.doi.org/10.1016/j.addbeh.2021.107170
work_keys_str_mv AT merianosashleyl concurrentuseofecigarettesandcannabisandassociatedcovid19symptomstestinganddiagnosisamongstudentecigaretteusersatfourusuniversities
AT russellalexm concurrentuseofecigarettesandcannabisandassociatedcovid19symptomstestinganddiagnosisamongstudentecigaretteusersatfourusuniversities
AT mahabeegittensemelinda concurrentuseofecigarettesandcannabisandassociatedcovid19symptomstestinganddiagnosisamongstudentecigaretteusersatfourusuniversities
AT barryadame concurrentuseofecigarettesandcannabisandassociatedcovid19symptomstestinganddiagnosisamongstudentecigaretteusersatfourusuniversities
AT yangmeng concurrentuseofecigarettesandcannabisandassociatedcovid19symptomstestinganddiagnosisamongstudentecigaretteusersatfourusuniversities
AT linhsienchang concurrentuseofecigarettesandcannabisandassociatedcovid19symptomstestinganddiagnosisamongstudentecigaretteusersatfourusuniversities